NTRA is expected to report earnings to fall -8.69% to -71 cents per share on May 02

A.I.dvisor
at Tickeron.com
05/01/24
Loading...
NTRA - Natera
Natera Earnings Graph
Q1'24
Est.
$-0.71
Q4'23
Beat
by $0.12
Q3'23
Beat
by $0.01
Q2'23
Beat
by $0.12
Q1'23
Missed
by $0.07
The last earnings report on December 31 showed earnings per share of -65 cents, beating the estimate of -77 cents. P/B Ratio (14.684) is normal, around the industry mean (22.483). P/E Ratio (0.000) is within average values for comparable stocks, (82.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.589). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (9.881) is also within normal values, averaging (51.692). With 621.87K shares outstanding, the current market capitalization sits at 11.04B.
View a ticker or compare two or three
NTRADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a genetic testing company which develops proprietary bioinformatics-based technology

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
13011 McCallen Pass
Phone
+1 650 980-9190
Employees
3018
Web
https://www.natera.com